Trending Insights
Frequently Asked Questions
-
What value is the predictive genetic testing & consumer/wellness genomics market expected to touch by 2033?
The global predictive genetic testing & consumer/wellness genomics market is expected to touch USD 13.33 billion in 2033.
-
What CAGR is the predictive genetic testing & consumer/wellness genomics market expected by 2033?
The predictive genetic testing & consumer/wellness genomics market is expected to exhibit a CAGR of 13.64% by 2033.
-
Which are the driving factors of the predictive genetic testing & consumer/wellness genomics market?
Novel alliances and global awareness are some of the driving factors in the predictive genetic testing & consumer/wellness genomics market.
-
Which are the top companies operating in the predictive genetic testing & consumer/wellness genomics market?
3andMe, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Myriad Genetics, Inc (U.S.), Agilent Technologies (U.S.), Abbott Laboratories (U.S.) are some of the top companies in the predictive genetic testing & consumer/wellness genomics market.